DaVita (MEX:DVA) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DVA DaVita Inc MEX:DVA
76 GF Score
Price MXN3,358.09
GF Value MXN2,478.09
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:DVA
76GF Score
DaVita Inc MEX:DVA
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DaVita (MEX:DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of MXN3,358.09 is trading 35.5% above its estimated GF Value™ of MXN2,478.09. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MEX:DVA:

  • Short Ratio:
  • GF Value™: MXN2,478.09 vs. price of MXN3,358.09 (35.5% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
76GF Score

Get the complete analysis for MEX:DVA

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,358.09
Price
MXN2,478.09
GF Value